Bacterial gene loss as a mechanism for gain of antimicrobial resistance

Current Opinion in Microbiology

Volumn 15, Issue 5, 2012, Pages 583-587

  Torok M E ^a,b,c   Chantratita, N ^d   Peacock, S J ^a,b,c,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PENICILLIN BINDING PROTEIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AUSTRALIA; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; COMPARATIVE GENOMIC HYBRIDIZATION; CULTURE MEDIUM; GENE DELETION; GENE LOSS; GENOMICS; HUMAN; MELIOIDOSIS; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; SOUTHEAST ASIA; WILD TYPE;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE DELETION; HUMANS; MELIOIDOSIS; MOLECULAR TYPING; PENICILLIN-BINDING PROTEINS;

BACILLUS (BACTERIUM); BACTERIA (MICROORGANISMS); BURKHOLDERIA PSEUDOMALLEI; NEGIBACTERIA;

EID: 84868126398     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2012.07.008     Document Type: Review

References (32)

1. van Hoek A.H., Mevius D., Guerra B., Mullany P., Roberts A.P., Aarts H.J. Acquired antibiotic resistance genes: an overview. Front Microbiol 2011, 2:203.
2. Chambers H.F. Methicillin-resistant staphylococci. Clin Microbiol Rev 1988, 1:173-186.
3. Bush K. Bench-to-bedside review: the role of beta-lactamases in antibiotic-resistant Gram-negative infections. Crit Care 2010, 14:224.
4. Patel G., Bonomo R.A. Status report on carbapenemases: challenges and prospects. Expert Rev Anti Infect Ther 2011, 9:555-570.
5. Nordmann P., Poirel L., Walsh T.R., Livermore D.M. The emerging NDM carbapenemases. Trends Microbiol 2011, 19:588-595.
6. Papp-Wallace K.M., Endimiani A., Taracila M.A., Bonomo R.A. Carbapenems: past, present, and future. Antimicrob Agents Chemother 2011, 55:4943-4960.
7. Musser J.M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995, 8:496-514.
8. Wiersinga W.J., van der Poll T., White N.J., Day N.P., Peacock S.J. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006, 4:272-282.
9. Burtnick M.N., Woods D.E. Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother 1999, 43:2648-2656.
10. Viktorov D.V., Zakharova I.B., Podshivalova M.V., Kalinkina E.V., Merinova O.A., Ageeva N.P., Antonov V.A., Merinova L.K., Alekseev V.V. High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species. Trans R Soc Trop Med Hyg 2008, 102(Suppl. 1):S103-S110.
11. Godfrey A.J., Wong S., Dance D.A., Chaowagul W., Bryan L.E. Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase. Antimicrob Agents Chemother 1991, 35:1635-1640.
12. Livermore D.M., Chau P.Y., Wong A.I., Leung Y.K. beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance. J Antimicrob Chemother 1987, 20:313-321.
13. Moore R.A., DeShazer D., Reckseidler S., Weissman A., Woods D.E. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 1999, 43:465-470.
14. Schweizer H.P. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2003, 2:48-62.
15. Wuthiekanun V., Amornchai P., Saiprom N., Chantratita N., Chierakul W., Koh G.C., Chaowagul W., Day N.P., Limmathurotsakul D., Peacock S.J. Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast Thailand. Antimicrob Agents Chemother 2011, 55:5388-5391.
16. Jenney A.W., Lum G., Fisher D.A., Currie B.J. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 2001, 17:109-113.
17. Limmathurotsakul D., Peacock S.J. Melioidosis: a clinical overview. Br Med Bull 2011, 99:125-139. Recent review article of clinical and microbiological features and treatment of melioidosis.
18. Limmathurotsakul D., Chaowagul W., Chierakul W., Stepniewska K., Maharjan B., Wuthiekanun V., White N.J., Day N.P., Peacock S.J. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006, 43:979-986.
19. Sarovich D.S., Price E.P., Von Schulze A.T., Cook J.M., Mayo M., Watson L.M., Richardson L., Seymour M.L., Tuanyok A., Engelthaler D.M., et al. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia. PLoS One 2012, 7:e30789.
20. Chantratita N., Rholl D.A., Sim B., Wuthiekanun V., Limmathurotsakul D., Amornchai P., Thanwisai A., Chua H.H., Ooi W.F., Holden M.T., et al. Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei. Proc Natl Acad Sci U S A 2011, 108:17165-17170.
21. Peacock S.J., Chieng G., Cheng A.C., Dance D.A., Amornchai P., Wongsuvan G., Teerawattanasook N., Chierakul W., Day N.P., Wuthiekanun V. Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 2005, 43:5359-5361.
22. Amornchai P., Chierakul W., Wuthiekanun V., Mahakhunkijcharoen Y., Phetsouvanh R., Currie B.J., Newton P.N., van Vinh Chau N., Wongratanacheewin S., Day N.P., Peacock S.J. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol 2007, 45:3774-3776.
23. Maharjan B., Chantratita N., Vesaratchavest M., Cheng A., Wuthiekanun V., Chierakul W., Chaowagul W., Day N.P., Peacock S.J. Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol 2005, 43:6032-6034.
24. Sim B.M., Chantratita N., Ooi W.F., Nandi T., Tewhey R., Wuthiekanun V., Thaipadungpanit J., Tumapa S., Ariyaratne P., Sung W.K., et al. Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol 2010, 11:R89.
25. Hayes M.V., Orr D.C. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 1983, 12:119-126.
26. Spratt B.G. Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. Proc Natl Acad Sci U S A 1975, 72:2999-3003.
27. Spratt B.G. Temperature-sensitive cell division mutants of Escherichia coli with thermolabile penicillin-binding proteins. J Bacteriol 1977, 131:293-305.
28. Tumapa S., Holden M.T., Vesaratchavest M., Wuthiekanun V., Limmathurotsakul D., Chierakul W., Feil E.J., Currie B.J., Day N.P., Nierman W.C., Peacock S.J. Burkholderia pseudomallei genome plasticity associated with genomic island variation. BMC Genomics 2008, 9:190.
29. Sim S.H., Yu Y., Lin C.H., Karuturi R.K., Wuthiekanun V., Tuanyok A., Chua H.H., Ong C., Paramalingam S.S., Tan G., et al. The core and accessory genomes of Burkholderia pseudomallei: implications for human melioidosis. PLoS Pathog 2008, 4:e1000178.
30. Tuanyok A., Leadem B.R., Auerbach R.K., Beckstrom-Sternberg S.M., Beckstrom-Sternberg J.S., Mayo M., Wuthiekanun V., Brettin T.S., Nierman W.C., Peacock S.J., et al. Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics 2008, 9:566.
31. Price E.P., Hornstra H.M., Limmathurotsakul D., Max T.L., Sarovich D.S., Vogler A.J., Dale J.L., Ginther J.L., Leadem B., Colman R.E., et al. Within-host evolution of Burkholderia pseudomallei in four cases of acute melioidosis. PLoS Pathog 2010, 6:e1000725.
32. Trunck L.A., Propst K.L., Wuthiekanun V., Tuanyok A., Beckstrom-Sternberg S.M., Beckstrom-Sternberg J.S., Peacock S.J., Keim P., Dow S.W., Schweizer H.P. Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. PLoS Negl Trop Dis 2009, 3:e519.